Syneron Candela’s PicoWay Laser Receives New FDA Clearance

Syneron Medical, a global market leader in the esthetic medical device marketplace, announced earlier this spring that the PicoWay laser received U.S. Food and Druf Administration (FDA) clearance for the treatment of pigmented lesions. This latest approval expands upon its FDA clearance for the removal of tattoos late last year.

The laser is now an FDA approved option to reverse uneven skin tone, blotches, and uneven pigmentation, restore radiant skin, reduce sun spots, take care of freckles, and rid dark marks from acne. PicoWay uses ultra-short picosecond (trillionths of a second) pulses to break down the melanin pigment into the smallest particles. It’s gentler and safer compared to other treatments because it mechanically shatters pigment with minimal to no heat, and the pigment is then eliminated naturally by the body.

Patients only need one or two treatments, spaced three to four weeks apart. Additionally, PicoWay is suitable for all skin types, including Asian skin tones, which dermatologists have reported great results. Since the PicoWay laser emits less heat than traditional lasers and leaves the surrounding skin undamaged, there’s minimal pain and patients find it’s more comfortable than traditional therapies. Plus, aftercare is minimal. Dark areas darken and slough off over a few days and can easily be covered with makeup in the meantime. In research by Syneron Candela, 96 percent of discolorations had good or complete clearance, and 86 percent of patients were satisfied with the results.

Suggested Articles

Unrealistic expectations of self-image driven by social media lead to disappointed clients.

The FDA granted Erchonia 510(k) market clearance to market its EVRL for the temporary relief of chronic neck and shoulder pain.

Discover some of the most common spa marketing mistakes, and a few ideas on how to circumvent them.